Search - tctmd.com

Displaying 61 - 72 of 72

Sort: Relevancy | Date

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Michael O'Riordan

May 19, 2016

News Conference News EuroPCR 2016

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

Michael O'Riordan

May 18, 2016

News Conference News EuroPCR 2016

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

Michael O'Riordan

May 17, 2016

News Conference News EuroPCR 2016

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Shelley Wood

May 16, 2016

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

Presentation EuroPCR 2013

First Report of the DEFLECT I Trial

Presenter: Michael Mullen

May 22, 2013

Presentation EuroPCR 2012

Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold

Presenter: 12690|Michael Haude

May 18, 2012

News Conference News EuroPCR 2012

Strong Showing for Bioabsorbable-Scaffold DES

Caitlin E. Cox

May 16, 2012

Video

» On Record

Valve Durability: What to Watch For

May 29, 2024

Advertisement

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Transradial PCI Shows Consistent Benefit in All ACS Patients: MATRIX Access

No Safety Net: TAVR Can Be Done at Centers Without Surgical Backup, German Study Suggests

Of Hands and Hearts: Upper-Extremity Dysfunction Common Early After Transradial PCI

Reassuring Registry Data Suggest Scaffold Thrombosis Rates with BVS Declining

Last Window for BMS Closes as LEADERS-FREE Supports DES in High-Bleeding-Risk ACS

EuroPCR 2016: Mitral Innovations, LAA Closure, and ‘TAVI, TAVI, TAVI’

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

First Report of the DEFLECT I Trial

Twelve-month clinical and angiographic results of the multicenter first-in-man BIOSOLVE-I study with the Paclitaxel-Eluting Bioabsorbable Magnesium Scaffold

Strong Showing for Bioabsorbable-Scaffold DES

Valve Durability: What to Watch For

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content